DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Wegovy - 2 Noom - 1 Geoff Cook - 1 Cook - 1 Dr - 1 Adonis Saremi - 1 They'll - 1 — - 1
Top related locs:
U.S United States Denver Michigan
Top related orgs:
FDA - 2 CNBC - 1 U.S . Food - 1 Drug Administration - 1 Service - 1 Business - 1 Virta - 1 Getty - 1

Search resuls for: "Noom's"


5 mentions found


☆ Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
  + stars: | 2024-09-12 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +5 min
Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149. Noom has offered weight loss programs for years, and consumers can already try to access those branded medications through its platform. Compounded GLP-1 medications are typically much cheaper than their branded counterparts. Most insurance plans cover GLP-1s when they are used to treat diabetes, but coverage of the weight loss drugs is less widespread. Consumers can get started with the Noom GLP-1 RX program by filling out an intake form on the website.
Persons: Wegovy, Noom, Geoff Cook, Cook, Dr, Adonis Saremi, They'll Organizations: CNBC, U.S . Food, Drug Administration, FDA Locations: U.S, United States
☆ Healthcare companies are promising to help patients quit Wegovy. There's just one problem with that.
  + stars: | 2023-12-19 | by ( ) www.businessinsider.com   time to read: +11 min
Inkinen said Virta can help patients quit GLP-1 drugs and keep weight off by adjusting the foods they eat to help them feel full, similar to how the drugs reduce feelings of hunger. About 82% of patients taking Wegovy experience gastrointestinal issues like nausea and diarrhea. WeightWatchers didn't provide Business Insider with published data to support its claims that it can help people keep weight off after quitting weight-loss drugs. AdvertisementHe also advises the weight-loss startup Calibrate, which tapers some patients off GLP-1 drugs after they reach a certain body-mass index. GLP-1 drugs also slash the risk of heart attacks, strokes, and cardiac-related death.
Persons: —, Michael Albert, aren't, Sami Inkinen, Inkinen, Virta, Michael Siluk, Noom's, Linda Anegawa, Carolina Rudah, tirzepatide, Mounjaro, Zepbound —, Eli Lilly, Ozempic, Wegovy, Randy Seeley, Seeley, Robyn Phelps, it's, Robert Kushner, Kushner, Florian Gaertner, It's, Albert, Lisa, she's, I'm Organizations: Service, Business, FDA, Virta, Getty, Nordisk, Michigan Nutrition Obesity Research, University of Michigan, Novo Nordisk, Northwestern University Locations: Denver, Michigan
☆ Noom quietly started writing prescriptions for trendy new weight-loss drugs
  + stars: | 2023-03-07 | by ( ) www.businessinsider.com   time to read: +4 min
The popular weight-loss app Noom quietly launched a new program that offers some users access to prescription anti-obesity medications. Called Noom Clinical, the program is meant to "build additional support" for app users, a company spokesperson said in a statement to Insider. Startups like Noom want to capitalize on a surge in demand for new weight-loss drugsSaeju Jeong, Co-founder & CEO, Noom Piaras Ó Mídheach/Sportsfile for Web Summit via Getty Images)Noom's foray into prescribing medication comes as demand for weight-loss drugs surges. NoomNoom, which introduced its weight loss app in 2017, is backed by venture firm Oak HC/FT and private-equity giant Silver Lake. According to the spokesperson, Noom began rolling out the new prescription-drug program to a small number of users in the fall.
☆ Elon Musk went to war — then made up — with Apple. Here's what happened.
  + stars: | 2022-12-04 | by ( Matt Turner | Jordan Parker Erb | Hallam Bullock | ) www.businessinsider.com   time to read: +4 min
On the agenda today:But first: Jordan Parker Erb, the author of Insider's 10 Things in Tech newsletter, is taking us behind the scenes of Elon Musk's feud with Apple. Tim Cook and Elon Musk Justin Sullivan/Getty Images and Philip Pacheco/AFP via Getty ImagesThis week, Elon Musk, the world's richest man and new Twitter owner, declared "war" with the world's biggest tech company: Apple. At the heart of the issue was Apple's 30% App Store fee, our associate editor Jordan Parker Erb writes. Here's what went down:Sign up for 10 Things in Tech to get stories like these right in your inbox. Edited by Jordan Parker Erb, Hallam Bullock, and Lisa Ryan.
☆ Noom sells psychology-driven weight loss — but former employees say they were unprepared for and overwhelmed by users' eating disorders, depression, and trauma
  + stars: | 2022-12-01 | by ( ) www.businessinsider.com   time to read: +31 min
Before joining Noom, users fill out a questionnaire asking about what diet programs or mental health apps they've used in the past. Very overly optimistic and happy, doesn't acknowledge what I'm really saying," one Noom user wrote on Reddit. Some of the coaches Insider interviewed said they were interacting with Noom users within two weeks of starting. Emotional bandwidthRachel Clair was hired as a Noom coach in 2018, at a time when the coaching staff grew from 60 to about 200. Annette Riedl/picture alliance via Getty ImagesIn October, 500 more Noom coaches were abruptly called into a virtual meeting and laid off.
0 next >>
Total: 5